Alnylam Pharmace. buy William Blair
Summary
This prediction is currently active. The BUY prediction by William_Blair for Alnylam Pharmace. has seen massive gains of 63.91%. This prediction currently runs until 08.04.25. The prediction end date can be changed by William_Blair at any time. William_Blair has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Alnylam Pharmace. | 2.115% | 2.115% |
iShares Core DAX® | 1.395% | -0.272% |
iShares Nasdaq 100 | 2.287% | 6.912% |
iShares Nikkei 225® | 1.617% | 3.038% |
iShares S&P 500 | 0.659% | 3.687% |
Comments by William_Blair for this prediction
In the thread Alnylam Pharmace. diskutieren